相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。5α-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis
Madison Lyon et al.
JOURNAL OF UROLOGY (2022)
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
Jonas F. Ludvigsson et al.
CLINICAL EPIDEMIOLOGY (2021)
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
Fei Li et al.
NATURE COMMUNICATIONS (2021)
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
D. A. Leach et al.
NATURE COMMUNICATIONS (2021)
被撤回的出版物: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial (Publication with Expression of Concern. See vol. 8, 2022) (Retracted article. See vol. 9, 2022)
John McCoy et al.
FRONTIERS IN MEDICINE (2021)
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)
M. Montopoli et al.
ANNALS OF ONCOLOGY (2020)
Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)
Jasper Fuk-Woo Chan et al.
CLINICAL INFECTIOUS DISEASES (2020)
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The Gabrin sign
Carlos Gustavo Wambier et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Viral and host factors related to the clinical outcome of COVID-19
Xiaonan Zhang et al.
NATURE (2020)
Does androgen deprivation therapy protect against severe complications from COVID-19?
V. G. Patel et al.
ANNALS OF ONCOLOGY (2020)
Androgen deprivation and SARS-CoV-2 in men with prostate cancer
M. Koskinen et al.
ANNALS OF ONCOLOGY (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
Hannah Peckham et al.
NATURE COMMUNICATIONS (2020)
A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer
Lee S. Schwartzberg et al.
CLINICAL CANCER RESEARCH (2017)
Pharmacokinetic Drug Interaction Studies with Enzalutamide
Jacqueline A. Gibbons et al.
CLINICAL PHARMACOKINETICS (2015)
Androgen receptor and androgen-dependent gene expression in lung
Laura Mikkonen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
分享论文
